Osage County Health Department is taking names and phone numbers of individuals who would like to receive the COVID-19 vaccine. Please call (785) 828-3117 during business hours (Mon - Thurs 8 am to 6:30 pm) to be put on this list. When the Health Department has vaccine in stock, they will call individuals to make an appointment to come in to receive the vaccine. Currently, the only site in Osage County to receive the vaccine is at the Osage County Health Department, 103 E. 9th St, Lyndon, KS. 

Osage County Health Department will pause administration of the Johnson & Johnson vaccine (see article below). If you have signed up to receive a J&J vaccination, you will be offered Moderna instead. If you do not wish to receive the Moderna vaccine, you may wait until the pause is lifted or another option becomes available. OCHD does not offer the Pfizer vaccine.

For Immediate Release
April 13, 2021
Kansas Pauses Johnson & Johnson Administration
TOPEKA – The Kansas Department of Health and Environment (KDHE) announces that Kansas will
pause administration of the Johnson & Johnson (Janssen) COVID-19 vaccine following an announcement
from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration
(FDA) this morning. There are reports of six recipients in the United States who developed a rare disorder
involving blood clots within about two weeks of vaccination. No known cases have been reported in
Kansas to date.
“Just as important as getting vaccines into arms -- is making sure those vaccines are safe,” Governor
Laura Kelly said. “While this appears to have affected six people in the nearly seven million doses
administered, out of an abundance of caution, Kansas will suspend Johnson and Johnson until the CDC
and FDA clear it for use again. In the meantime, we anticipate our shipments of Pfizer and Moderna to
continue and we will build on the one-third of Kansans who have already received their first dose of the
COVID-19 vaccine.”
The federal government will further study links between the vaccine and the rare blood clotting disorder.
An emergency meeting of the CDC’s advisory committee has been scheduled for Wednesday.
KDHE asks providers with Johnson & Johnson vaccine to pause administration of the vaccine
immediately and to place the supply into storage while material is reviewed. After KDHE has reviewed
the findings from the federal government, further guidance will be given to providers on next steps.
Those who have received the Johnson & Johnson vaccine should contact their health care provider if they
have any symptoms and report any illness to the VAERS Reporting System, https://vaers.hhs.gov.
The week of April 19th, Kansas is anticipated to receive the following doses:
• 39,780 Pfizer Prime
• 38,610 Pfizer Boost
• 29,000 Moderna Prime
• 27,800 Moderna Boost
Joint CDC and FDA Statement
As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been
administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare and
severe type of blood clot in individuals after receiving the J&J vaccine. In these cases, a type of blood clot
called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets
(thrombocytopenia). All six cases occurred among women between the ages of 18 and 48, and symptoms
occurred 6 to 13 days after vaccination. Treatment of this specific type of blood clot is different from the
treatment that might typically be administered. Usually, an anticoagulant drug called heparin is used to
treat blood clots. In this setting, administration of heparin may be dangerous, and alternative treatments
need to be given.
CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on
Wednesday to further review these cases and assess their potential significance. FDA will review that
analysis as it also investigates these cases. Until that process is complete, we are recommending a pause in
the use of this vaccine out of an abundance of caution. This is important, in part, to ensure that the health
care provider community is aware of the potential for these adverse events and can plan for proper
recognition and management due to the unique treatment required with this type of blood clot.
Right now, these adverse events appear to be extremely rare. COVID-19 vaccine safety is a top priority for
the federal government, and we take all reports of health problems following COVID-19 vaccination very
seriously. People who have received the J&J vaccine who develop severe headache, abdominal pain, leg
pain, or shortness of breath within three weeks after vaccination should contact their health care provider.
Health care providers are asked to report adverse events to the Vaccine Adverse Event Reporting System
CDC and FDA will provide additional information and answer questions later today at a media briefing.

PHASES for vaccine distribution

Below is the latest information for COVID-19.

Moderna COVID-19 Facts Sheet

Press Release from the Osage County Health Department dated July 29, 2020

 

KDHE Amends Travel Quarantine List 

 

 COVID-19 - Telephone Numbers for Assistance

 

Executive Order No. 20-68 Establishing a face covering protocol.  

 

Resolution 20-07 Opting Out of Executive Order 20-68

 

Osage County Face Covering Protocol adopted on 11/23/2020